GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34243
Submission : 2019-10-18
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34243
Submission : 2019-10-18
Status : Active
Type : IV
FINISHED DOSAGE FORMULATIONS
ISONIAZID; PYRAZINAMIDE; RIFAMPIN
Drug : RIFATER
Dosage Form : TABLET; ORAL
Application Number : 50705
Country : US
Patented : No
Drug : SYNTHROID
Dosage Form : TABLET; ORAL
Application Number : 21402
Country : US
Patented : No
Drug : MEGESTROL ACETATE
Dosage Form : TABLET; ORAL
Application Number : 72423
Country : US
Patented : No
Drug : METFORMIN HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Application Number : 77880
Country : US
Patented : No
SODIUM PHENYLBUTYRATE; TAURURSODIOL
Drug : RELYVRIO
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 216660
Country : US
Patented : Yes
Drug : PERSANTINE
Dosage Form : TABLET; ORAL
Application Number : 12836
Country : US
Patented : No
Drug : AGGRENOX
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 20884
Country : US
Patented : No
Drug : NICORETTE (MINT)
Dosage Form : GUM, CHEWING; BUCCAL
Application Number : 20066
Country : US
Patented : No
Drug : NICORETTE
Dosage Form : GUM, CHEWING; BUCCAL
Application Number : 20066
Country : US
Patented : Yes
Drug : PRIMIDONE
Dosage Form : TABLET; ORAL
Application Number : 84903
Country : US
Patented : No
EXCIPIENTS BY APPLICATIONS